Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 16 12:10PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.39 Insider Own22.30% Shs Outstand38.26M Perf Week10.95%
Market Cap85.32M Forward P/E- EPS next Y-1.42 Insider Trans0.00% Shs Float29.73M Perf Month1.36%
Income-53.37M PEG- EPS next Q-0.42 Inst Own19.64% Short Float3.57% Perf Quarter-25.67%
Sales0.00M P/S- EPS this Y58.74% Inst Trans-3.45% Short Ratio6.12 Perf Half Y-36.47%
Book/sh1.85 P/B1.21 EPS next Y13.40% ROA-64.88% Short Interest1.06M Perf Year-29.21%
Cash/sh1.44 P/C1.55 EPS next 5Y-2.49% ROE-74.43% 52W Range1.24 - 5.00 Perf YTD-46.20%
Dividend Est.- P/FCF- EPS past 5Y28.36% ROI-112.30% 52W High-55.40% Beta0.33
Dividend TTM- Quick Ratio5.38 Sales past 5Y-20.00% Gross Margin- 52W Low80.57% ATR (14)0.17
Dividend Ex-Date- Current Ratio5.38 EPS Y/Y TTM66.52% Oper. Margin0.00% RSI (14)54.69 Volatility8.96% 8.33%
Employees54 Debt/Eq0.01 Sales Y/Y TTM-100.00% Profit Margin- Recom1.40 Target Price10.70
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q84.19% Payout- Rel Volume0.44 Prev Close2.18
Sales Surprise- EPS Surprise12.82% Sales Q/Q- EarningsMay 13 BMO Avg Volume173.32K Price2.23
SMA2014.07% SMA50-4.21% SMA200-12.28% Trades Volume34,722 Change2.29%
Date Action Analyst Rating Change Price Target Change
Jun-28-24Initiated Rodman & Renshaw Buy $8
Oct-04-21Initiated Mizuho Buy $6
Jun-04-21Resumed Robert W. Baird Outperform $5
Jun-29-20Initiated Piper Sandler Overweight $6
Feb-11-20Initiated Robert W. Baird Outperform $6
Nov-15-19Downgrade Raymond James Outperform → Mkt Perform
Sep-13-19Resumed Raymond James Outperform
Mar-07-17Initiated Ladenburg Thalmann Buy $18
May-13-24 08:31AM
Apr-29-24 04:01AM
Apr-11-24 08:30AM
Mar-20-24 09:35AM
07:00AM Loading…
Mar-18-24 07:00AM
Jan-16-24 05:05PM
Jan-03-24 07:00AM
Jan-02-24 07:00AM
Dec-11-23 04:05PM
Nov-21-23 07:00AM
Nov-13-23 07:00AM
Oct-24-23 12:30PM
Oct-03-23 09:55AM
Sep-05-23 07:00AM
07:00AM Loading…
Aug-14-23 07:00AM
Aug-13-23 10:44AM
Jul-12-23 07:00AM
Jun-20-23 12:30PM
Jun-04-23 07:11AM
May-25-23 05:10PM
May-15-23 07:00AM
Apr-26-23 04:05PM
Apr-12-23 07:00AM
Apr-04-23 11:10AM
Mar-24-23 07:00AM
Mar-17-23 12:26PM
Mar-16-23 04:05PM
Jan-17-23 05:13PM
08:00AM Loading…
Jan-11-23 07:00AM
Nov-21-22 07:00AM
Nov-16-22 05:20AM
Nov-14-22 07:00AM
Nov-07-22 08:05AM
Oct-26-22 08:19AM
Oct-17-22 07:00AM
Oct-12-22 07:00AM
Oct-05-22 08:05AM
Sep-27-22 08:15AM
Sep-07-22 07:00AM
Sep-06-22 07:00AM
Sep-04-22 06:05PM
Aug-12-22 07:00AM
Jul-21-22 07:47AM
Jul-14-22 11:37AM
Jul-12-22 11:20AM
Jul-11-22 11:58AM
Jul-08-22 11:48AM
Jul-07-22 11:22AM
Jul-04-22 11:49AM
Jun-29-22 12:44PM
Jun-28-22 11:52AM
Jun-27-22 07:00AM
Jun-17-22 11:16AM
Jun-13-22 12:01PM
Jun-10-22 10:51AM
Jun-09-22 10:48AM
Jun-08-22 10:14AM
Jun-07-22 11:30AM
Jun-06-22 10:13AM
Jun-03-22 10:51AM
Jun-02-22 12:09PM
May-31-22 11:26AM
May-26-22 05:00PM
May-25-22 12:07PM
May-24-22 10:58AM
May-23-22 11:46AM
May-19-22 06:15AM
May-13-22 07:00AM
Apr-09-22 08:57AM
Mar-11-22 07:00AM
Mar-02-22 07:00AM
Mar-01-22 09:45AM
Feb-25-22 08:25AM
Feb-15-22 10:14AM
Feb-08-22 07:56AM
Feb-03-22 05:38PM
Jan-31-22 07:00AM
Jan-24-22 07:00AM
Jan-21-22 05:38PM
Jan-19-22 02:07PM
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.